Emerging role of proteomics in advancing diagnosis,prognosis,and treatment of liver cancerOA
Emerging role of proteomics in advancing diagnosis,prognosis,and treatment of liver cancer
Yunyang Xu;Jiarui Li;Xingyu Luo;Ze Xiang;Zhe Yang;Xuyong Wei;Xiao Xu;Jian Chen
Zhejiang University School of Medicine,Hangzhou,Zhejiang,ChinaZhejiang University School of Medicine,Hangzhou,Zhejiang,ChinaDepartment of Hepatobiliary and Pancreatic Surgery,Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province,Shulan(Hangzhou)Hospital,Shulan International Medical College,Zhejiang Shuren University,Hangzhou,Zhejiang,ChinaZhejiang University School of Medicine,Hangzhou,Zhejiang,ChinaDepartment of Hepatobiliary and Pancreatic Surgery,Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province,Shulan(Hangzhou)Hospital,Shulan International Medical College,Zhejiang Shuren University,Hangzhou,Zhejiang,ChinaDepartment of Hepatobiliary and Pancreatic Surgery,Hangzhou First People's Hospital,Hangzhou,Zhejiang,ChinaHepatobiliary Center,The First Affiliated Hospital of Nanjing Medical University,Nanjing,Jiangsu,China||Institute of Translational Medicine,Zhejiang University,Hangzhou,Zhejiang,ChinaHepatobiliary Center,The First Affiliated Hospital of Nanjing Medical University,Nanjing,Jiangsu,China
Liver cancer(LC)Hepatocellular carcinoma(HCC)Cholangiocarcinoma(CCA)ProteomicsDiagnosisPrognosisBiomarkersTargeted therapy
Liver cancer(LC)Hepatocellular carcinoma(HCC)Cholangiocarcinoma(CCA)ProteomicsDiagnosisPrognosisBiomarkersTargeted therapy
《肝脏研究（英文）》 2026 (2)
121-132,12
This work was supported by the National Natural Science Foundation of China(No.82300743),the Zhejiang Provincial Natural Science Foundation of China(No.LQ23H160044).
评论